Exact Mass: 452.2464814
Exact Mass Matches: 452.2464814
Found 500 metabolites which its exact mass value is equals to given mass value 452.2464814,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diphenoxylate
C30H32N2O2 (452.24636519999996)
A meperidine congener used as an antidiarrheal, usually in combination with atropine. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity. This medication is classified as a Schedule V under the Controlled Substances Act by the Food and Drug Administration (FDA) and the DEA in the United States when used in preparations. When diphenoxylate is used alone, it is classified as a Schedule II. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
Bisbenzimide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D020011 - Protective Agents > D011837 - Radiation-Protective Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D011838 - Radiation-Sensitizing Agents Bisbenzimide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=23491-52-3 (retrieved 2024-08-14) (CAS RN: 23491-52-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Rhodojaponin I
(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide
(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is found in fruits. (14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is a constituent of Physalis peruviana (Cape gooseberry) Constituent of Physalis peruviana (Cape gooseberry). (14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is found in fruits.
Tafluprost
C25H34F2O5 (452.23741780000006)
Tafluprost is only found in individuals that have used or taken this drug. It is a prostaglandin analogue used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. Tafluprost was approved for use in the U.S. on February 10, 2012.Tafluprost is a prostaglandin F2a analogue. Specifically, Tafluprost is a prostanoid selective FP receptor agonist that is believed to reduce the intraocular pressure (IOP) by increasing the outflow of aqueous humor. Studies in animals and man suggest that the main mechanism of action is increased uveoscleral outflow. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78568 - Prostaglandin Analogue
PA(10:0/8:0)
C21H41O8P (452.25389160000003)
PA(10:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/8:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/10:0)
C21H41O8P (452.25389160000003)
PA(8:0/10:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/10:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of capric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
Delapril
(E)-5-hydroxy-N-[3-[5-[3-[[(E)-5-hydroxy-3-methylpent-2-enoyl]amino]propyl]-3,6-dioxopiperazin-2-yl]propyl]-3-methylpent-2-enamide
[(1S,2R,4aR,8aR)-1-acetyloxy-1,4a-dimethyl-6-oxo-7-propan-2-ylidene-2,3,4,5,8,8a-hexahydronaphthalen-2-yl] 3-acetyloxy-2-hydroxy-2-methylbutanoate
2-Picenecarboxylic acid
(20R,22R)-21,24-epoxy-5beta-hydroxy-1-oxowitha-2,9(11),25(27)-trienolide|withametelinol-A
10-hidroxy 4,17-dihydro 17 beta-tchibangensine
C29H32N4O (452.25759819999996)
Toxin III (Helminthosporium carbonum)
C21H32N4O7 (452.22708819999997)
2??,5??,9??-Trihydroxy-10??,13??-diacetoxy-4??,20-epoxytaxa-11-ene
(15R)-scutecyprol A|15beta-scutecyprol A|15R-scutecyprol A|clerodin hemiacetal
(2beta,3beta,5alpha,6alpha)-2,3-bis(acetyloxy)-8,13-epoxy-6,9-dihydroxylabd-14-en-11-one|(3R,4aR,6S,6aS,8R,9S,10aS,10bS)-8,9-bis(acetyloxy)-3-ethenyldodecahydro-6,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one|excolabdone A
7alpha,12alpha,14beta,15beta-tetrahydroxy-3beta,19-diacetoxy-ent-kaur-16-ene|pharicinin D
3beta,6alpha,11beta,15beta-tetrahydroxy-1alpha,7beta-diacetoxy-ent-kaur-16-ene|nervonin F
1alpha,3beta,6alpha,15beta-tetrahydroxy-7beta,11beta-diacetoxy-ent-kaur-16-ene|nervonin I
(1alpha,5alpha,6beta,7beta)-1,6-bis(acetyloxy)-8,13-epoxy-7,9-dihydroxylabd-14-en-11-one|(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10-bis(acetyloxy)-3-ethenyldodecahydro-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one|excolabdone B
antidesmanin E|antidesmanin F|erythro-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol|threo-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol
(20R,22R)-17beta-hydroxy-1,12-dioxowitha-2,5,24-trien-26,22-olide|jaborosalactone 44
9alpha,10beta-diacetoxy-2alpha,5alpha,14beta-trihydroxy-4,20-epoxy,11-taxene
3-epi-14,15-dihydrocaryoptinol|3beta-hydroxy-14,15-dihydroclerodin|ajubractin E
7beta,11alpha-diacetoxy-8,13-epoxy-6beta,9alpha-dihydroxylabd-14-ene-1-one|coleoforskolin
(3R,4S,5R,6R,2R,3S)-3-O-(2,3-diacetoxy-2-methylbutyryl)cuauhtemone
1-[11-(ferulyloxy)undecanoyl]glycerol|2,3-dihydroxypropyl 11-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}undecanoate
24,25,26,27-tetra-norapotirucalla-(apoeupha)-6alpha-acetoxy-7alpha-hydroxy-1,14,20,22-tetraen-21,23-epoxy-3-one|6alpha-O-acetyl-7-deacetylnimocinol
(22R)-4beta,27-dihydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4,27-dihydroxy-1-oxo-witha-2,5,16,24-tetraenolide
(20R,22R)-14,20-Dihydroxy-1-oxowitha-2,5,16,22-tetraenolide
3,22beta-dihydroxy-24,29-dinor-1(10),3,5-friedelatriene-2,7,21-trione
(22R,Z)-16beta,27-dihydroxy-1-oxo-witha-2,5,17(20),24-tetraenolide
3,7,9-trihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
(20R,22R)-14,20-Dihydroxy-1-oxowitha-2,4,6,24-tetraenolide|14alpha,20alphaF-dihydroxy-1-oxo-22R-witha-2,4,6,24-tetraenolide
16-en-27-deoxywithaferin A|27-deoxy-Delta(16)-withaferin A|5beta,6beta-epoxy-4beta-hydroxy-1-oxo-witha-2,16,24-trienolide
1-(18-hydroxyoleoyl)-sn-glycrol 3-phosphate
C21H41O8P (452.25389160000003)
Diphenoxylate
C30H32N2O2 (452.24636519999996)
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
C28H36O5_2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydro-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)
C24H36O8_Butanoic acid, 3-(acetyloxy)-2-hydroxy-2-methyl-, (1S,2R,4aR,8aR)-1-(acetyloxy)decahydro-1,4a-dimethyl-7-(1-methylethylidene)-6-oxo-2-naphthalenyl ester
(2R,4aS,6aR,6aS,14aS,14bR)-10,11-dihydroxy-2,4a,6a,6a,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid
[(1S,2R,4aR,8aR)-1-acetyloxy-1,4a-dimethyl-6-oxo-7-propan-2-ylidene-2,3,4,5,8,8a-hexahydronaphthalen-2-yl] 3-acetyloxy-2-hydroxy-2-methylbutanoate_major
Ala Ile Ser Tyr
C21H32N4O7 (452.22708819999997)
Ala Ile Tyr Ser
C21H32N4O7 (452.22708819999997)
Ala Leu Ser Tyr
C21H32N4O7 (452.22708819999997)
Ala Leu Tyr Ser
C21H32N4O7 (452.22708819999997)
Ala Ser Ile Tyr
C21H32N4O7 (452.22708819999997)
Ala Ser Leu Tyr
C21H32N4O7 (452.22708819999997)
Ala Ser Tyr Ile
C21H32N4O7 (452.22708819999997)
Ala Ser Tyr Leu
C21H32N4O7 (452.22708819999997)
Ala Thr Val Tyr
C21H32N4O7 (452.22708819999997)
Ala Thr Tyr Val
C21H32N4O7 (452.22708819999997)
Ala Val Thr Tyr
C21H32N4O7 (452.22708819999997)
Ala Val Tyr Thr
C21H32N4O7 (452.22708819999997)
Ala Tyr Ile Ser
C21H32N4O7 (452.22708819999997)
b-D-Glucopyranosiduronic acid, (3a,5b)-17-oxoestran-3-yl
b-D-Glucopyranosiduronic acid, (3b,5a)-17-oxoestran-3-yl
b-D-Glucopyranosiduronic acid, (3b,5b)-17-oxoestran-3-yl
Gly Leu Tyr Thr
C21H32N4O7 (452.22708819999997)
Gly Thr Ile Tyr
C21H32N4O7 (452.22708819999997)
Gly Thr Leu Tyr
C21H32N4O7 (452.22708819999997)
Gly Thr Tyr Ile
C21H32N4O7 (452.22708819999997)
Gly Thr Tyr Leu
C21H32N4O7 (452.22708819999997)
Gly Tyr Ile Thr
C21H32N4O7 (452.22708819999997)
Gly Tyr Leu Thr
C21H32N4O7 (452.22708819999997)
Gly Tyr Thr Ile
C21H32N4O7 (452.22708819999997)
Gly Tyr Thr Leu
C21H32N4O7 (452.22708819999997)
His Ile Pro Ser
His Ile Ser Pro
His Leu Pro Ser
His Leu Ser Pro
His Pro Ile Ser
His Pro Leu Ser
His Pro Ser Ile
His Pro Ser Leu
His Pro Thr Val
His Pro Val Thr
His Ser Ile Pro
His Ser Leu Pro
His Ser Pro Ile
His Ser Pro Leu
His Thr Pro Val
His Thr Val Pro
His Val Pro Thr
His Val Thr Pro
Ile Ala Ser Tyr
C21H32N4O7 (452.22708819999997)
Ile Ala Tyr Ser
C21H32N4O7 (452.22708819999997)
Ile Phe Ser Ser
C21H32N4O7 (452.22708819999997)
Ile Gly Thr Tyr
C21H32N4O7 (452.22708819999997)
Ile Gly Tyr Thr
C21H32N4O7 (452.22708819999997)
Ile His Pro Ser
Ile His Ser Pro
Ile Pro His Ser
Ile Pro Ser His
Ile Ser Ala Tyr
C21H32N4O7 (452.22708819999997)
Ile Ser Phe Ser
C21H32N4O7 (452.22708819999997)
Ile Ser His Pro
Ile Ser Pro His
Ile Ser Ser Phe
C21H32N4O7 (452.22708819999997)
Ile Ser Tyr Ala
C21H32N4O7 (452.22708819999997)
Ile Thr Gly Tyr
C21H32N4O7 (452.22708819999997)
Ile Thr Tyr Gly
C21H32N4O7 (452.22708819999997)
Ile Tyr Ala Ser
C21H32N4O7 (452.22708819999997)
Ile Tyr Gly Thr
C21H32N4O7 (452.22708819999997)
Ile Tyr Ser Ala
C21H32N4O7 (452.22708819999997)
Ile Tyr Thr Gly
C21H32N4O7 (452.22708819999997)
Leu Ala Ser Tyr
C21H32N4O7 (452.22708819999997)
Leu Ala Tyr Ser
C21H32N4O7 (452.22708819999997)
Leu Phe Ser Ser
C21H32N4O7 (452.22708819999997)
Leu Gly Thr Tyr
C21H32N4O7 (452.22708819999997)
Leu Gly Tyr Thr
C21H32N4O7 (452.22708819999997)
Leu His Pro Ser
Leu His Ser Pro
Leu Pro His Ser
Leu Pro Ser His
Leu Ser Ala Tyr
C21H32N4O7 (452.22708819999997)
Leu Ser Phe Ser
C21H32N4O7 (452.22708819999997)
Leu Ser His Pro
Leu Ser Pro His
Leu Ser Ser Phe
C21H32N4O7 (452.22708819999997)
Leu Ser Tyr Ala
C21H32N4O7 (452.22708819999997)
Leu Thr Gly Tyr
C21H32N4O7 (452.22708819999997)
Leu Thr Tyr Gly
C21H32N4O7 (452.22708819999997)
Leu Tyr Ala Ser
C21H32N4O7 (452.22708819999997)
Leu Tyr Gly Thr
C21H32N4O7 (452.22708819999997)
Leu Tyr Ser Ala
C21H32N4O7 (452.22708819999997)
Leu Tyr Thr Gly
C21H32N4O7 (452.22708819999997)
Pro His Ile Ser
Pro His Leu Ser
Pro His Ser Ile
Pro His Ser Leu
Pro His Thr Val
Pro His Val Thr
Pro Ile His Ser
Pro Ile Ser His
Pro Leu His Ser
Pro Leu Ser His
Pro Ser His Ile
Pro Ser His Leu
Pro Ser Ile His
Pro Ser Leu His
Pro Thr His Val
Pro Thr Val His
Pro Val His Thr
Pro Val Thr His
Ser Ala Ile Tyr
C21H32N4O7 (452.22708819999997)
Ser Ala Leu Tyr
C21H32N4O7 (452.22708819999997)
Ser Ala Tyr Ile
C21H32N4O7 (452.22708819999997)
Ser Ala Tyr Leu
C21H32N4O7 (452.22708819999997)
Ser Phe Ile Ser
C21H32N4O7 (452.22708819999997)
Ser Phe Leu Ser
C21H32N4O7 (452.22708819999997)
Ser Phe Ser Ile
C21H32N4O7 (452.22708819999997)
Ser Phe Ser Leu
C21H32N4O7 (452.22708819999997)
Ser Phe Thr Val
C21H32N4O7 (452.22708819999997)
Ser Phe Val Thr
C21H32N4O7 (452.22708819999997)
Ser His Ile Pro
Ser His Leu Pro
Ser His Pro Ile
Ser His Pro Leu
Ser Ile Ala Tyr
C21H32N4O7 (452.22708819999997)
Ser Ile Phe Ser
C21H32N4O7 (452.22708819999997)
Ser Ile His Pro
Ser Ile Pro His
Ser Ile Ser Phe
C21H32N4O7 (452.22708819999997)
Ser Ile Tyr Ala
C21H32N4O7 (452.22708819999997)
Ser Leu Ala Tyr
C21H32N4O7 (452.22708819999997)
Ser Leu Phe Ser
C21H32N4O7 (452.22708819999997)
Ser Leu His Pro
Ser Leu Pro His
Ser Leu Ser Phe
C21H32N4O7 (452.22708819999997)
Ser Leu Tyr Ala
C21H32N4O7 (452.22708819999997)
Ser Pro His Ile
Ser Pro His Leu
Ser Pro Ile His
Ser Pro Leu His
Ser Ser Phe Ile
C21H32N4O7 (452.22708819999997)
Ser Ser Phe Leu
C21H32N4O7 (452.22708819999997)
Ser Ser Ile Phe
C21H32N4O7 (452.22708819999997)
Ser Ser Leu Phe
C21H32N4O7 (452.22708819999997)
Ser Thr Phe Val
C21H32N4O7 (452.22708819999997)
Ser Thr Val Phe
C21H32N4O7 (452.22708819999997)
Ser Val Phe Thr
C21H32N4O7 (452.22708819999997)
Ser Val Thr Phe
C21H32N4O7 (452.22708819999997)
Ser Tyr Ala Ile
C21H32N4O7 (452.22708819999997)
Ser Tyr Ala Leu
C21H32N4O7 (452.22708819999997)
Ser Tyr Ile Ala
C21H32N4O7 (452.22708819999997)
Ser Tyr Leu Ala
C21H32N4O7 (452.22708819999997)
Thr Ala Val Tyr
C21H32N4O7 (452.22708819999997)
Thr His Pro Val
Thr His Val Pro
Thr Pro His Val
Thr Pro Val His
Thr Val His Pro
Thr Val Pro His
Val His Pro Thr
Val His Thr Pro
Val Pro His Thr
Val Pro Thr His
Val Thr His Pro
Val Thr Pro His
Val Thr Tyr Ala
C21H32N4O7 (452.22708819999997)
Tafluprost
C25H34F2O5 (452.23741780000006)
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78568 - Prostaglandin Analogue
octadecanoic acid-1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl ester
(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide
Delapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
tert-Butyl-{3-[2-(diphenyl-phosphinoyl)-ethylidene]-4-methylene-cyclohexyloxy}-dimethyl-silane
GDC-0349
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor GDC-0349 is a potent and selective ATP-competitive mTOR inhibitor with a Ki of 3.8 nM. GDC-0349 inhibits of both mTORC1 and mTORC2 complexes. GDC-0349 is a potent and selective ATP-competitive mTOR inhibitor with a Ki of 3.8 nM. GDC-0349 inhibits of both mTORC1 and mTORC2 complexes.
Bofutrelvir
COVID info from PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C281 - Antiviral Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Paraminabeolide F
A withanolide that is 18,22:23,26-diepoxyergosta-1,4-diene substituted by oxo groups at positions 3, 18 and 26. It has been isolated from a Formosan soft coral Paraminabea acronocephala.
EleutherazineB
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines
[(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-18-hydroxyoctadec-9-enoate
C21H41O8P (452.25389160000003)
1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(2-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea
1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(3-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea
1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(4-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea
[(1S,3S,4R,6R,8S,9S,10R,11R,14R,15R,17R)-17-acetyloxy-4,10,15-trihydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.01,11.04,9.06,8]heptadecan-3-yl] acetate
[(E)-2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1S,6R)-1,2,6-trimethylcyclohex-2-en-1-yl]oct-5-enyl] hydrogen sulfate
C25H40O5S (452.25963100000007)
(2S,3S,3aR,9bR)-7-[3-[dimethylamino(oxo)methyl]phenyl]-1-ethyl-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-[3-[dimethylamino(oxo)methyl]phenyl]-1-ethyl-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
(2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
(1-Acetyloxy-3-phosphonooxypropan-2-yl) hexadecanoate
C21H41O8P (452.25389160000003)
(2-Nonanoyloxy-3-phosphonooxypropyl) nonanoate
C21H41O8P (452.25389160000003)
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) pentadecanoate
C21H41O8P (452.25389160000003)
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate
C21H41O8P (452.25389160000003)
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate
C21H41O8P (452.25389160000003)
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) undecanoate
C21H41O8P (452.25389160000003)
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate
C21H41O8P (452.25389160000003)
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) decanoate
C21H41O8P (452.25389160000003)
Bisbenzimide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D020011 - Protective Agents > D011837 - Radiation-Protective Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D011838 - Radiation-Sensitizing Agents
[(2R)-2-octanoyloxy-3-phosphonooxypropyl] decanoate
C21H41O8P (452.25389160000003)
phosphatidic acid 18:0
C21H41O8P (452.25389160000003)
A phosphatidic acid in which the two acyl groups contain a total of 18 carbons and no double bonds.
GSK3326595
GSK3326595 is a protein arginine methyltransferase 5 (PRMT5) inhibitor. GSK3326595 decreases SARS-CoV-2 infection, inhibits cancer cell proliferation and induces pro-inflammatory macrophage polarization and increases hepatic triglyceride levels without affecting atherosclerosis. GSK3326595 can be used for research of relapsed/refractory mantle cell lymphoma[1][2][3][4][5].
(1r,2r,8s,10r,11r,15r,16s)-15-(furan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-10-yl acetate
(1r,5r,8r)-8-[(1r,3as,3bs,5as,9ar,11as)-5a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(1s,2r,4r,6r,7s,10r,11r,16r,18r)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate
(1r,2r,3r,4s,6s,9s,10s,11s,13s,14s,16s)-6-(acetyloxy)-2,16-dihydroxy-13-(hydroxymethyl)-5,5,9-trimethyl-12-oxapentacyclo[11.2.1.1¹¹,¹⁴.0¹,¹⁰.0⁴,⁹]heptadecan-3-yl acetate
(1s,2r,4s,8r,9r,10s,14s,15r)-9-(acetyloxy)-2-hydroxy-1,10,14-trimethyl-5-methylidene-6-oxo-7,18-dioxatricyclo[13.2.1.0⁴,⁸]octadecan-14-yl acetate
8-(acetyloxy)-3,6,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
6-(1-{3a-hydroxy-9a,11a-dimethyl-9-oxo-3h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
(2-{2-[(1s,2r,4as,8ar)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl)oxysulfonic acid
C25H40O5S (452.25963100000007)
1-(furan-2-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
(2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid
(1s,2s,6s,7s,9r,13r,14s,15r,16s,17r)-11,14-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-3-oxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-16-yl acetate
(1r,3as,3br,9ar,9bs,11as)-1-[(1r)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,9bh,10h-cyclopenta[a]phenanthrene-9,11-dione
6-(1-{6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
20-methyl-7,17,21,31-tetraazaoctacyclo[19.10.1.0³,¹⁹.0⁵,¹⁷.0⁶,¹⁴.0⁸,¹³.0²²,²⁷.0²⁸,³²]dotriaconta-6(14),8,10,12,18,22,24,26-octaen-11-ol
C29H32N4O (452.25759819999996)
11,14-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-3-oxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-16-yl acetate
(1s,2r,7s,9r,11s,12s,15r,16s)-2,16-dimethyl-15-[(1s,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
5-[12-(chloromethylidene)-4-hydroxy-3,6,9-trimethyltetracyclo[6.6.1.0²,⁶.0¹¹,¹⁵]pentadeca-7,11(15)-dien-3-yl]-2-methylpentane-1,2,3,4-tetrol
C25H37ClO5 (452.23293820000004)
6-(acetyloxy)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-hexahydro-2h-naphtho[2,1-b]pyran-5-yl acetate
[4-(acetyloxy)-5-hydroxy-5-(hydroxymethyl)-1,2-dimethyl-1-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-2h-naphthalen-4a-yl]methyl acetate
4-[(1r,2r)-2-[4-(3,3-dimethylpenta-1,4-dien-1-yl)-2-methoxyphenoxy]-1-hydroxy-3,3-dimethylpent-4-en-1-yl]-2-methoxyphenol
3,10,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,10,12,12a,13,14-hexahydro-7h-picene-2,9-dione
(1s,3br,4r,5ar,9ar,9br,11s,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate
(1r,2r,3r,4s,6s,9r,10s,11s,13s,14s,16s)-6-(acetyloxy)-2,16-dihydroxy-13-(hydroxymethyl)-5,5,9-trimethyl-12-oxapentacyclo[11.2.1.1¹¹,¹⁴.0¹,¹⁰.0⁴,⁹]heptadecan-3-yl acetate
10-(acetyloxy)-3-ethenyl-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-hexahydro-2h-naphtho[2,1-b]pyran-6-yl acetate
17β-hydroxy-14α,20α-epoxy-1-oxo-(22r)-witha-3,5,24-trienolide
{"Ingredient_id": "HBIN001994","Ingredient_name": "17\u03b2-hydroxy-14\u03b1,20\u03b1-epoxy-1-oxo-(22r)-witha-3,5,24-trienolide","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "CC1=C(C(=O)OC(C1)C2(C3(CCC4(C3(CCC5C4CC=C6C5(C(=O)CC=C6)C)C)O2)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10091","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2alpha,5alpha,9alpha-trihydroxy-10beta,13alpha-diacetoxy-4beta,20-epoxytaxa-11-ene
{"Ingredient_id": "HBIN005247","Ingredient_name": "2alpha,5alpha,9alpha-trihydroxy-10beta,13alpha-diacetoxy-4beta,20-epoxytaxa-11-ene","Alias": "2\u03b1,5\u03b1,9\u03b1-trihydroxy-10\u03b2,13\u03b1-diacetoxy-4\u03b2,20-epoxytaxa-11-ene","Ingredient_formula": "C24H36O8","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C4(C3C(C(C2(C)C)CC1OC(=O)C)O)CO4)O)C)O)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32118;21688","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5β,6β-epoxy-4β-hydroxy-1-oxowitha-2,14,24-trienolide
{"Ingredient_id": "HBIN011454","Ingredient_name": "5\u03b2,6\u03b2-epoxy-4\u03b2-hydroxy-1-oxowitha-2,14,24-trienolide","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "CC12CC=C3C(C1CCC2C4COC5(CC4OC(=O)C5=C)C)CCC6(C3(C(=O)C=CC6)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7127","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5β,6β-epoxy-4β-hydroxy-1-oxo-witha-2,16,24-trienolide
{"Ingredient_id": "HBIN011455","Ingredient_name": "5\u03b2,6\u03b2-epoxy-4\u03b2-hydroxy-1-oxo-witha-2,16,24-trienolide","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7128","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6α-o-acetyl-7-deacetylnimocinol
{"Ingredient_id": "HBIN012215","Ingredient_name": "6\u03b1-o-acetyl-7-deacetylnimocinol","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "364","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
benzoylramanone
{"Ingredient_id": "HBIN017830","Ingredient_name": "benzoylramanone","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "CC(=O)C1CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)OC(=O)C5=CC=CC=C5)C)O","Ingredient_weight": "452.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2268","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101974123","DrugBank_id": "NA"}
(1r,3ar,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(1r,3s,4r,7s,8r,11r,12r)-11-(acetyloxy)-8-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadecan-3-yl acetate
(2-{2-[(1s,2s,4ar)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl)oxysulfonic acid
C25H40O5S (452.25963100000007)
(1s,2r,4as,8ar)-1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl (2r,3r)-2-(acetyloxy)-3-hydroxy-2-methylbutanoate
10'-(acetyloxy)-2',5',9'-trihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-13'-yl acetate
4,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,8,13,14,14b-octahydropicene-3,6-dione
methyl 5-hydroxy-12-{1-[(3-methylbut-2-enoyl)oxy]ethyl}-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
(1s,3r,4s,7r,8s,11s,12s)-11-(acetyloxy)-8-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadecan-3-yl acetate
(1r,5r,8r)-8-[(1r,3as,3bs,5r,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(2s,3s,4s)-5-[(1s,2s,3r,4s,6r,9s,12e)-12-(chloromethylidene)-4-hydroxy-3,6,9-trimethyltetracyclo[6.6.1.0²,⁶.0¹¹,¹⁵]pentadeca-7,11(15)-dien-3-yl]-2-methylpentane-1,2,3,4-tetrol
C25H37ClO5 (452.23293820000004)
3-[(1s,3s,4r,5r,8r,9r,12s,13s)-5-(butanoyloxy)-5,9,12-trimethyl-10-oxo-3-(2-oxopropyl)-2,11-dioxatricyclo[6.4.1.0⁴,¹³]tridecan-12-yl]propanoic acid
6-(acetyloxy)-3,8,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1r,3br,4s,5r,5ar,9ar,9br,11as)-1-(furan-2-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
(6bs,8ar,9s,11r,12as,12bs,14ar)-3,9,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione
(1r,3r,4s,7r,8r,11s,12r)-11-(acetyloxy)-8-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadecan-3-yl acetate
(1s,2r,7s,9r,11s,12s,15r,16s)-2,16-dimethyl-15-[(1r,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
1-acetyl-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl benzoate
(3r,4ar,5s,6s,6as,10s,10ar,10bs)-10-(acetyloxy)-3-ethenyl-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-hexahydro-2h-naphtho[2,1-b]pyran-6-yl acetate
2,3-bis(acetyloxy)-5-hydroxy-5-isopropyl-2a,7a-dimethyl-hexahydro-1ah-azuleno[5,6-b]oxiren-6-yl 2-methylbut-2-enoate
3-[5-(butanoyloxy)-5,9,12-trimethyl-10-oxo-3-(2-oxopropyl)-2,11-dioxatricyclo[6.4.1.0⁴,¹³]tridecan-12-yl]propanoic acid
[5-(furan-3-yl)-2-[2-(1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl)ethyl]pentyl]oxysulfonic acid
C25H40O5S (452.25963100000007)
7-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(6bs,8ar,9s,11s,12as,12bs,14ar)-3,9,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione
(1r,3ar,3br,4r,5as,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
8-{11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(1's,2s,2'r,3'r,5's,8'r,9'r,10'r,14's)-10'-(acetyloxy)-2',5',14'-trihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl acetate
(3r,4ar,6s,6as,8r,9s,10as,10bs)-8-(acetyloxy)-3-ethenyl-6,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-hexahydro-2h-naphtho[2,1-b]pyran-9-yl acetate
[(2s)-2-{2-[(1r,2r,4as)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl]oxysulfonic acid
C25H40O5S (452.25963100000007)
(1r,5s,8r)-8-[(1r,3as,3bs,9ar,9bs,11r,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
6-(acetyloxy)-3,7,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1'r,2r,2's,4'r,5's,6'r,8'r,11'r)-5'-[(2s,3as,5r,6ar)-5-methoxy-hexahydrofuro[2,3-b]furan-2-yl]-11'-methoxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-2'-yl acetate
(9r)-2,16-dimethyl-15-[(1r,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxatetracyclo[9.7.0.0³,⁹.0¹²,¹⁶]octadeca-2,4-dien-7-one
(1r)-1-{[(2s,3e,12bs)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]methyl}-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol
C29H32N4O (452.25759819999996)
n-[2-({4-[(4e)-5-{4-[3-(furan-3-yl)propyl]furan-2-yl}-4-methylpent-4-en-1-yl]furan-2-yl}formamido)ethyl]ethanimidic acid
(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one
(1r,5r,8r)-8-[(11r)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
[1-(2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-6-(furan-3-yl)-3-methylhexan-2-yl]oxysulfonic acid
C25H40O5S (452.25963100000007)
(1r,4s,5r,5ar,9ar,9br,11as)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
15-(furan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-10-yl acetate
(3as,4r,6r,10s,11r,11as)-10-hydroxy-6,10-dimethyl-3-methylidene-11-[(2-methylpropanoyl)oxy]-2,5-dioxo-octahydrocyclodeca[b]furan-4-yl 2-methylbutanoate
[(1r,2s,4as,10br,12as)-8-hydroxy-2,4a,7,10b,12a-pentamethyl-9-oxo-1-(2-oxopropyl)-3,4,11,12-tetrahydro-1h-chrysen-2-yl]acetic acid
8-(acetyloxy)-5-{5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl}-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
7,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione
(2r,4s,4ar,6as,12bs,14as,14bs)-4,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,8,13,14,14b-octahydropicene-3,6-dione
(1r,3r,4r,7s,8s,11s,12r)-11-(acetyloxy)-8-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadecan-3-yl acetate
(6r)-6-{1-[(1z,2s,3as,3bs,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-ylidene]ethyl}-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid
(2z,6s,7s)-8-[(2r)-4-[(3z)-5-(acetyloxy)-4-methylpent-3-en-1-yl]-5-oxo-2h-furan-2-yl]-6,7-dihydroxy-3,7-dimethyloct-2-en-1-yl acetate
[(5e)-2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]oct-5-en-1-yl]oxysulfonic acid
C25H40O5S (452.25963100000007)
2,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-4,5,6,13,14,14b-hexahydro-1h-picene-3,8-dione
(2e)-n-{3-[(2r,5r)-5-(3-{[(2e)-1,5-dihydroxy-3-methylpent-2-en-1-ylidene]amino}propyl)-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}-5-hydroxy-3-methylpent-2-enimidic acid
(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11s,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(1s,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2r,3r,6r)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
[(1s,3r,4s,5s,8r,9r,10r,12r,14r,16s)-16-(acetyloxy)-3,4,8,14-tetrahydroxy-5,9-dimethyl-13-methylidenetetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
[(2s,3r)-1-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-6-(furan-3-yl)-3-methylhexan-2-yl]oxysulfonic acid
C25H40O5S (452.25963100000007)
1-({3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}methyl)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol
C29H32N4O (452.25759819999996)
4-[(1r,2r)-2-{4-[(1e)-3,3-dimethylpenta-1,4-dien-1-yl]-2-methoxyphenoxy}-1-hydroxy-3,3-dimethylpent-4-en-1-yl]-2-methoxyphenol
(6r)-6-[(1s)-1-[(3as,3bs,6s,9ar,9bs,11as)-6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
(1s,2r,3r,4r,6s,8s,9r,10s,11s,13s,15r)-6-(acetyloxy)-2,8,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1s,2r,3r,4r,6s,8s,9s,10s,11s,13s,15r)-6-(acetyloxy)-2,8,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
n-[3-(5-{3-[(1,5-dihydroxy-3-methylpent-2-en-1-ylidene)amino]propyl}-3,6-dihydroxy-2,5-dihydropyrazin-2-yl)propyl]-5-hydroxy-3-methylpent-2-enimidic acid
9-(acetyloxy)-3-ethenyl-6,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-hexahydro-2h-naphtho[2,1-b]pyran-8-yl acetate
[(5e)-2-[3-(furan-3-yl)propyl]-6-methyl-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-1-yl]oxysulfonic acid
C25H40O5S (452.25963100000007)
6-(1-{3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
(1s,3bs,4r,5s,5as,9as,9bs,11ar)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
2-(acetyloxy)-3,6,8,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,3s,4r,7r,8r,11r,12r)-11-(acetyloxy)-8-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadecan-3-yl acetate
6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate
8-{4-[5-(acetyloxy)-4-methylpent-3-en-1-yl]-5-oxo-2h-furan-2-yl}-6,7-dihydroxy-3,7-dimethyloct-2-en-1-yl acetate
(1s,2r,6s,7r,9r,11s,12s,16s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one
(1s,2r,3r,4r,6s,8s,9s,10s,11s,13s,15r)-6-(acetyloxy)-3,8,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1r,2s,5s,6r,10r,11s,12r,15r,19s)-6-(furan-3-yl)-11-(methoxymethoxy)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one
(3r,6s,8r,12s,15s,17r)-5,8,14,17-tetrahydroxy-3,12-bis(2-methylpropyl)-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione
(1r,2r,10r,11s,14r,15s,16r)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one
(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11r,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(1s,2r,4ar,8ar)-1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl (2s,3s)-3-(acetyloxy)-2-hydroxy-2-methylbutanoate
(1s,3s,7r,8r,9s,13s,14s,17r)-8-(acetyloxy)-17-hydroxy-9,13,17-trimethyl-4-methylidene-5-oxo-6,18-dioxatricyclo[12.3.1.0³,⁷]octadecan-13-yl acetate
methyl (1r,12r,19r)-5-hydroxy-12-[(1s)-1-[(3-methylbut-2-enoyl)oxy]ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl 3-(acetyloxy)-2-hydroxy-2-methylbutanoate
{2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]oct-5-en-1-yl}oxysulfonic acid
C25H40O5S (452.25963100000007)
1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(3r,4ar,5s,6s,6as,10s,10ar,10bs)-6-(acetyloxy)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-hexahydro-2h-naphtho[2,1-b]pyran-5-yl acetate
(1s,2r,3r,4s,6r,7s,9s,10s,11s,13s,15r)-6-(acetyloxy)-3,7,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
n-{1-[(2r,5s,6r)-5-{[(4s,5s,6r)-5-(dimethylamino)-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-2-methylpropanamide
(1s,2s,6s,7s,9s,11s,13r,14s,15r,16s,17r)-11,14-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-3-oxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-16-yl acetate
2,16-dimethyl-15-{1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
methyl (6bs,8as,11r,12ar,12bs,14ar)-6b,8a,11,12b,14a-pentamethyl-2,4-dioxo-7h,8h,9h,10h,12h,12ah,13h,14h-phenanthro[2,1-f]isochromene-11-carboxylate
(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one
(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(6s)-6-[(1r)-1-[(1s,6s,9ar,9bs,11as)-1,6-dihydroxy-9a,11a-dimethyl-9-oxo-2h,3h,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
(1s,5'r,12s,13r,16s,18r,20s,21r)-5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-one
(1s,9r,11s,12s,15r,16s)-2,16-dimethyl-15-[(1r,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxatetracyclo[9.7.0.0³,⁹.0¹²,¹⁶]octadeca-2,4-dien-7-one
(2r,4as,6as,12br,14as,14br)-2,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-4,5,6,13,14,14b-hexahydro-1h-picene-3,8-dione
(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11s,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(6bs,7s,8ar,9s,11r,12as,12bs,14as)-3,7,9-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
(6bs,8ar,10s,11s,12as,12bs,14ar)-3,10,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,10,12,12a,13,14-hexahydro-7h-picene-2,9-dione
(1'r,2r,2'r,3'r,5's,8'r,9'r,10'r,13's)-10'-(acetyloxy)-2',5',9'-trihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-13'-yl acetate
(1r,4s,6r,7r)-7-[(1e,3e,5e,7e,9e)-10-[(2r,3s,6s)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
6-(acetyloxy)-2,8,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
2-[(2r,12s)-2,12-bis(acetyloxy)tridecyl]-4,6-dihydroxybenzoic acid
6-(1-{1,6-dihydroxy-9a,11a-dimethyl-9-oxo-2h,3h,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5s,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
3,7,9-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
(1s,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(1r,4r,5r,7s)-7-[(1r,3as,3bs,9ar,9bs,11as)-1-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-4,5-dimethyl-2-oxabicyclo[3.2.1]octan-3-one
[8-hydroxy-2,4a,7,10b,12a-pentamethyl-9-oxo-1-(2-oxopropyl)-3,4,11,12-tetrahydro-1h-chrysen-2-yl]acetic acid
2-[2,12-bis(acetyloxy)tridecyl]-4,6-dihydroxybenzoic acid
[(2s,5e)-2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1s)-2,6,6-trimethylcyclohex-2-en-1-yl]oct-5-en-1-yl]oxysulfonic acid
C25H40O5S (452.25963100000007)
(6r)-6-[(1r)-1-[(1s,3ar,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
6-(1-{2-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-ylidene}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
7-[10-(3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-one
1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl 2-(acetyloxy)-3-hydroxy-2-methylbutanoate
(1s,2r,6s,7r,9r,11r,15r,16r)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,12-dien-3-one
(1s,2r,4r,6s,7s,10r,11r,16r,18r)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate
(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11r,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(6r)-6-[(1r)-1-[(3ar,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-3h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
(1r,2r,10r,11s,14r,15r,16r)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one
(1s,2r,3r,4s,6r,7s,9r,10s,11s,13s,15r)-6-(acetyloxy)-3,7,11,15-tetrahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1s)-1-{[(2s,3e,12bs)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]methyl}-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol
C29H32N4O (452.25759819999996)
(2-{2-[(1r,2r,4as)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl)oxysulfonic acid
C25H40O5S (452.25963100000007)
{2-[3-(furan-3-yl)propyl]-6-methyl-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-1-yl}oxysulfonic acid
C25H40O5S (452.25963100000007)
(2s,3r,4s,11's,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2',5',12'-triene-4',7'-dione
(1r,3br,4s,5r,5as,9ar,9br,11as)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
8-{5-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
(1's,2s,3r,4s,10'r,11'r,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2',5',12'-triene-4',7'-dione
(6r)-6-[(1r)-1-[(1s,3br,9ar,9bs,11ar)-9a,11a-dimethyl-9-oxo-1h,2h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
methyl 6-[(1s,2r)-1-hydroxy-3-methoxy-2-octyl-3-oxopropyl]phenazine-1-carboxylate
2,16-dimethyl-15-{1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl}-8-oxatetracyclo[9.7.0.0³,⁹.0¹²,¹⁶]octadeca-2,4-dien-7-one
(1s,4ar,5r,6s,8r,8as)-5-[(2r,3ar,5r,6as)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(1r,3br,4s,5r,5ar,9ar,9br,11as)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(3r,4r,6r,8s,9s,10r,11r,14s,15r)-17-(acetyloxy)-4,10,15-trihydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-3-yl acetate
3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2',5',12'-triene-4',7'-dione
3,9,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione
(1s,3as,3bs,7s,9ar,9bs,11r,11as)-1-acetyl-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl benzoate
(2r,4as,6as,12bs,14as,14br)-7,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione
15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one
8-{11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
[16-(acetyloxy)-3,4,8,14-tetrahydroxy-5,9-dimethyl-13-methylidenetetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
8-{5a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
methyl 6-(1-hydroxy-3-methoxy-2-octyl-3-oxopropyl)phenazine-1-carboxylate
(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one
11-(acetyloxy)-8-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13,18-dioxatricyclo[10.3.2.1⁴,⁷]octadecan-3-yl acetate
(1r,3br,4s,5r,5as,9ar,9br,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
4-hydroxy-7-{1-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-4,5-dimethyl-2-oxabicyclo[3.2.1]octan-3-one
[(2s)-5-(furan-3-yl)-2-[2-(1,2,5,5-tetramethyl-2,3,4,6,7,8-hexahydronaphthalen-1-yl)ethyl]pentyl]oxysulfonic acid
C25H40O5S (452.25963100000007)